Biotricity Inc. (BTCY) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
203 REDWOOD PARKWAY REDWOOD CITY, CA 94065 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 MRQ | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 786 | 570 | 12,067 | 2,202 | 950 | 64 | |||
| Cash and cash equivalent | 786 | 570 | 12,067 | 2,202 | 950 | 64 | |||
| Receivables | 1,469 | 1,224 | 2,007 | 1,521 | 486 | 208 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,879 | 2,337 | 843 | 272 | 86 | 25 | |||
| Inventory | 1,879 | 2,337 | 843 | 272 | 86 | 25 | |||
| Deposits current assets | 336 | 589 | 406 | 327 | 137 | 101 | |||
| Other undisclosed current assets | 60 | ||||||||
| Total current assets: | 4,471 | 4,720 | 15,323 | 4,322 | 1,659 | 458 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,222 | 1,587 | 1,243 | 66 | 264 | ✕ | |||
| Property, plant and equipment | 16 | 22 | 27 | ||||||
| Long-term investments and receivables | 150 | 96 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 150 | 96 | |||||||
| Deposits noncurrent assets | 85 | 85 | 85 | 33 | 33 | ||||
| Other undisclosed noncurrent assets | 50 | 48 | |||||||
| Total noncurrent assets: | 1,472 | 1,790 | 1,355 | 116 | 346 | 33 | |||
| TOTAL ASSETS: | 5,943 | 6,511 | 16,678 | 4,438 | 2,004 | 491 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 9,613 | 5,042 | 2,596 | 2,520 | 1,522 | 1,401 | |||
| Accounts payable | 5,222 | 3,435 | 1,159 | 1,041 | 1,094 | 878 | |||
| Accrued liabilities | 4,370 | 1,607 | 1,436 | 1,479 | 428 | 522 | |||
| Other undisclosed accounts payable and accrued liabilities | 22 | ||||||||
| Debt | 11,636 | 4,774 | 1,540 | 4,278 | 2,068 | ||||
| Derivative instruments and hedges, liabilities | 992 | 1,008 | 521 | 3,634 | |||||
| Other undisclosed current liabilities | 457 | 336 | 210 | 58 | 213 | ||||
| Total current liabilities: | 22,699 | 11,161 | 4,867 | 10,490 | 3,803 | 1,401 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 10,856 | 13,050 | 13,603 | 57 | |||||
| Long-term debt, excluding current maturities | 10,856 | 13,050 | 12,483 | ||||||
| Liabilities, other than long-term debt | 2,365 | 2,146 | 352 | 410 | 1,145 | ||||
| Operating lease, liability | 929 | 1,386 | 1,120 | 57 | ✕ | ||||
| Derivative instruments and hedges, liabilities | 1,436 | 759 | 352 | 410 | 1,145 | ||||
| Other undisclosed noncurrent liabilities | 371 | ||||||||
| Total noncurrent liabilities: | 13,221 | 15,195 | 13,956 | 781 | 1,202 | ||||
| Other undisclosed liabilities | 868 | ||||||||
| Total liabilities: | 35,919 | 26,356 | 18,823 | 11,271 | 5,005 | 2,268 | |||
| Temporary equity, including noncontrolling interest | |||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (31,466) | (19,845) | (2,145) | (6,833) | (3,000) | (1,778) | |||
| Preferred stock | 0 | 0 | 0 | 0 | |||||
| Common stock | 10 | 53 | 51 | 39 | 36 | 35 | |||
| Additional paid in capital | 95,723 | 92,801 | 91,507 | 56,299 | 44,015 | 33,890 | |||
| Accumulated other comprehensive income (loss) | 32 | (153) | (769) | (634) | (857) | (755) | |||
| Accumulated deficit | (127,500) | (112,571) | (93,037) | (62,818) | (46,364) | (35,039) | |||
| Other undisclosed equity, attributable to parent | 269 | 25 | 102 | 281 | 169 | 91 | |||
| Other undisclosed equity | 1,489 | ||||||||
| Total equity: | (29,977) | (19,845) | (2,145) | (6,833) | (3,000) | (1,778) | |||
| TOTAL LIABILITIES AND EQUITY: | 5,943 | 6,511 | 16,678 | 4,438 | 2,004 | 491 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 TTM | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 12,063 | 9,639 | 7,650 | 3,385 | 1,418 | 398 | ||
| Cost of revenue | (3,707) | (4,197) | (3,080) | (1,871) | (725) | (249) | ||
| Gross profit: | 8,356 | 5,442 | 4,570 | 1,514 | 692 | 150 | ||
| Operating expenses | (17,185) | (20,852) | (22,591) | (14,865) | (11,623) | (8,742) | ||
| Operating income (loss): | (8,828) | (15,410) | (18,020) | (13,352) | (10,931) | (8,592) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (103) | (111) | 15 | (37) | ||||
| Interest and debt expense | (264) | (1,910) | (380) | 1,200 | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (9,195) | (17,431) | (18,385) | (12,188) | (10,931) | (8,592) | ||
| Other undisclosed loss from continuing operations before income taxes | (4,900) | (1,227) | (10,746) | (3,303) | (136) | |||
| Loss from continuing operations: | (14,094) | (18,658) | (29,130) | (15,491) | (11,067) | (8,592) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (29,130) | (15,491) | (11,067) | (8,592) | |
| Net loss attributable to parent: | (14,094) | (18,658) | (29,130) | (15,491) | (11,067) | (8,592) | ||
| Preferred stock dividends and other adjustments | (835) | (876) | (1,089) | (962) | (258) | |||
| Other undisclosed net income (loss) available to common stockholders, basic | 0 | |||||||
| Net loss available to common stockholders, diluted: | (14,929) | (19,534) | (30,219) | (16,453) | (11,325) | (8,592) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 TTM | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (14,094) | (18,658) | (29,130) | (15,491) | (11,067) | (8,592) | ||
| Comprehensive loss: | (14,094) | (18,658) | (29,130) | (15,491) | (11,067) | (8,592) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (650) | (260) | (1,223) | (146,839) | (360) | (112) | ||
| Comprehensive loss, net of tax, attributable to parent: | (14,744) | (18,918) | (30,354) | (162,330) | (11,427) | (8,704) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.